incyte corp (INCY:NASDAQ GS)

Executive Profile*

Background*

Mr. Roy A. Whitfield served as Chief Executive Officer of Hexagen PLC. Mr. Whitfield has over 20 years of management and governance experience in the biotechnology industry. He co-founded Incyte Corp., (formerly, Incyte Genomics, Inc.) in 1991 and served as its Chairman of the Board from November 2001 to June 24, 2003, Chief Executive Officer from June 1993 to November 2001, President from June 1991 to January 1997 and Treasurer from April 1991 to October 1995. At Incyte, ... he executed the first genomics initial public offering (IPO) and later raised over $700 million in financing. Mr. Whitfield served as President of Ideon Corporation from October 1989 to April 1991. From 1984 to 1989, he served Senior Operating and Business Development positions at Technicon Instruments Corporation and its predecessor company, Cooper Biomedical, Inc. Prior to his work at Technicon Instruments Cop., he spent seven years with Boston Consulting Group's international consulting practice. He serves as an Executive Chairman of BioSeek, Inc. He has been Chairman of Science and Business Advisory Board of Sciona, Inc., since June 2005. Mr. Whitfield has been a Director of Sciona, Inc., since June 2005; Solexa Inc. since August 2006; BioSeek, Inc. since February 6, 2006; Nektar Therapeutics since August 2000; Incyte Corporation since 1991 and Illumina Inc. since January 26, 2007. He serves as a Director of Illumina, Inc., and Inhale Therapeutics Inc. He has been a Member of the Scientific Advisory Board at Sciona, Inc., since June 2005. He served as a Director of Aurora Biosciences Corp. since September 1997. He served as a Director of Iconix Biosciences, Inc. (formerly, Iconix Pharmaceuticals Inc.), DiscoveRx Corporation, Biotechnology Industry Organization, and Hexagen PLC. He serves as a Member of Advisory Committee of InterWest Partners. He received the 1997 Northern California Entrepreneur of the Year Award for Life Sciences and the 1996 Best of Biotech Award for Most Creative and Significant Strategic Alliances. Mr. Whitfield holds a B.S. Degree with First Class Honors in Mathematics from Oxford University and an M.B.A. with Distinction, from Stanford University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
INCY:US	$23.04 USD	-0.13

COMPETITOR COMPENSATION